Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer

Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer

Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.

Thursday, October 2, 2025
Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

Clinical trial testing the efficacy of an experimental immunotherapeutic drug, Olvi-Vec.

Thursday, October 2, 2025
Investigational Device May Help Minimize Bleeding, Other Complications in Patients Undergoing Dialysis

Investigational Device May Help Minimize Bleeding, Other Complications in Patients Undergoing Dialysis

Sarasota Memorials Kolschowsky Research and Education Institute is among 10 research sites studying an investigational device designed to reduce the risk of bleeding complications in patients undergoing hemodialysis treatment.

Thursday, October 2, 2025
SMH-Sarasota Receives Emergency General Surgery Verification from American College of Surgeons

SMH-Sarasota Receives Emergency General Surgery Verification from American College of Surgeons

SMH-Sarasota is only the second hospital in Florida to earn this distinction, and the 13th in the nation.

Wednesday, October 1, 2025
Clinical Study of Nanosecond Pulsed Field Ablation for People with Benign Thyroid Nodules

Clinical Study of Nanosecond Pulsed Field Ablation for People with Benign Thyroid Nodules

The PRECISE-BTN study uses Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA) technology to treat patients with benign thyroid nodules (BTNs). 

Tuesday, September 30, 2025
RSS
123468910Last